Ildong Holdings Co., Ltd.
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 000230.KS | 000623.SZ | 067080.KQ | 016580.KS | 000963.SZ | 600750.SS | |
|---|---|---|---|---|---|---|
| Market cap | 67.86B | 20.20B | 182.93B | 188.54B | 46.26B | 14.57B |
| P/E (TTM) | — | 6.2 | — | — | 13.3 | 16.7 |
| Forward P/E | — | 7.7 | — | — | 10.5 | 15.3 |
| Price/book | — | 0.6 | — | — | 1.8 | 3.7 |
| Dividend yield | 1.69% | 2.97% | 1.49% | 2.94% | 3.58% | 6.07% |
| 1-year change | −29.94% | −18.15% | −36.66% | −5.64% | −34.33% | +4.27% |
| Today | −0.68% | +1.62% | −1.10% | −0.10% | +1.46% | +0.88% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.
Latest news
All 000230.KS news ›Ildong Pharmaceutical debuts Superamin brand to target Korea’s vitamin market
Ildong Pharmaceutical(249420) will roll out two products that combine active vitamin B complex with ingredients related to fatigue management, moving to target the vitamin market. Ildong Pharmaceutical said on the 14th it is launching a…
Ildong weighs Korea strategy as Xocova wins US, Europe PEP approvals
Ildong weighs resubmission as Shionogi's Xocova gains PEP traction abroad and eyes Korean path Ildong Pharmaceutical(249420)'s oral COVID-19 treatment "Xocova (active ingredient ensitrelvir)" has entered a long game to resubmit for new…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
biz.chosun.com2
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.